📮 Tensor Ventures — Decoded Newsletter April 2025 Edition
💚 New investment
We are happy to invest in QurieGen, revolutionizing cancer drug development with AI-driven molecular analysis. Backed by Tensor Ventures, Lighthouse Ventures, BSV Ventures, Moondust Ventures, 22 Hor Invest, and Tim Draper of Draper Associates, the startup has secured EUR 2.1 million in pre-seed funding.
Their breakthrough technology helps pharmaceutical companies develop cancer treatments faster and more cost-effectively. By analyzing how drugs interact with individual cells, QurieGen uncovers why some treatments fail, accelerating drug discovery and saving lives.
Founded by Dr. Eng. Kinga Matuła, whose personal battle with cancer fueled her mission, QurieGen has already won the Venture Challenge, earned a spot in the Silicon Valley Accelerator, and was selected for the NATO DIANA program, gaining EUR 100,000 in funding and access to top research facilities.
We believe QurieGen is redefining precision oncology, and this is just the beginning. Read the full story:
🤗 New Investment: QurieGen is transforming oncology through next-Gen single cell analysis
We are excited to announce that we invested in our deep tech TechBio startup QurieGen that has secured EUR 2.2 million in pre-seed funding to develop advanced AI-based technology aimed at accelerating drug development progress in oncology. Dr. Eng. Kinga Matula
🚀 Portfolio in action
dstack was featured at the NVIDIA GTC talk by EA.
Wultra hosted the webinar on “Why Post-Quantum Authentication Needs Your Attention Today”.
Openvibe was featured at 9to5Google blog.
Pointee launched Pointee's AI Support Agent – the first-ever agent for RPA and Intelligent Automation maintenance & ops.
Bioo tech launched their first installation in Riyadh.
👩🏽💻 Deep tech scene
Europe’s Quantum Ambitions: The EU unveiled a €1.5 billion investment package for quantum computing and communications, with a focus on developing sovereign technologies. This move aims to catch up with U.S. and Chinese progress and retain talent within the bloc.
China Expands AI Chip Supply Chain: In response to growing U.S. export restrictions, China accelerated local AI chip supply chain development, including partnerships between Baidu, Alibaba, and domestic foundries. It’s part of a broader effort to build resilience and reduce tech dependency.
Roche Bets Big on AI-Driven Biotech: Pharma giant Roche committed $50 billion to expand its U.S. manufacturing and R&D footprint, including a new AI-powered drug discovery center. This signals deepening convergence between biotech and artificial intelligence, with implications for startups focused on precision medicine and data-driven healthtech.
UK’s Crypto Future Hinges on Regulation: Industry leaders are urging the UK government to deliver regulatory clarity for cryptoassets amid rising global competition. With a significant portion of the population holding digital assets but limited VC traction, clear policy could unlock broader investment and innovation in the blockchain space.
📣 Events We loved
Angel Academy: Held in Olomouc by the Inovační centrum Olomouckého kraje, this event brought together new and seasoned angel investors. We shared insights on startup evaluation and saw strong interest in early-stage investing beyond the main hubs.
Lipo.ink Day: We attended an event by Lipo.ink in Liberec, focused on early-stage innovation. It offered valuable exposure to emerging founders and highlighted the strength of regional ecosystems.
Technology Day: At the University of Pardubice, we served on the expert jury evaluating scientific projects. It was a strong reminder of the potential in academic research and the importance of bridging it with venture capital.
Join our amazing events in May! 🚀
🔬Digital Biology with QurieGen in California - https://lu.ma/sy21ejag
☕️ DeepTech Momentum side event in Berlin - https://lu.ma/092dl5v2
Cheers,
The Tensor VC team